Adial Pharmaceuticals Inc.

11/14/2024 | Press release | Distributed by Public on 11/14/2024 07:35

Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder